-
Investing in Early-stage Therapies
… Phase I and II studies of inhaled levodopa for “off” rescue from biotech Civitas. After multiple rounds of venture … modification with close to $750,000 in pre-clinical funding from MJFF. Neuropore entered a collaboration with UCB in … its next study. Collaboration Benefits Receiving a grant from The Michael J. Fox Foundation brings more than …
-
Therapies for Tomorrow: How Better Clinical Trial Design Leads to Better Treatments
February 15, 2024
… 1925 Year I would like to receive news and resources from the Michael J. Fox Foundation. Save my information for … moves set in motion by research breakthroughs from the last year, the groundwork is being laid for even … participant living with Parkinson’s answer questions from the audience that were submitted in advance and also …
-
The Michael J. Fox Foundation Remembers Albert B. Glickman
May 2, 2013
… Foundation.” A native of Portland, Maine, Mr. Glickman rose from humble beginnings to become a pioneer in commercial … Museum. Mr. Glickman received a BS in political science from UCLA and a JD from UCLA Law School. He was a member of the California …
-
A Journey to the Moon—and to a Cure—Are within Our Reach
April 8, 2013
… of the Space Shuttle Discovery , and watched take off from the launch pad. So perhaps it’s no surprise that at his … at the U.S. Space & Rocket Center will be representatives from Serina Therapeutics, a biotech firm working in PD research, and from the University of Alabama at Birmingham’s Department of …
-
An Anti-Aging Cream to Slow Parkinson’s Disease?
September 6, 2013
… to detect, and then clear out, damaged mitochondria from the cell. In PD cases associated with mutations in … that causes the disease. So this team of researchers, from Howard Hughes Medical Institute and led by Kevan Shokat , PhD, and with support from The Michael J. Fox Foundation, decided to find a way to …
-
MJFF Brokers Industry Consortium to Advance Disease-modifying Therapies
February 4, 2015
… published today in Science Translational Medicine authors from biotechnology company Genentech and from MJFF share that they observed changes in lung tissue of … Leaders to Move Forward However, we’re not stepping back from LRRK2. This protein remains one of our top priority …